Complete remission of multiple satellite and in-transit melanoma metastases after sequential treatment with isolated limb perfusion and topical imiquimod-Reference-Cited by-同舟云学术

Complete remission of multiple satellite and in-transit melanoma metastases after sequential treatment with isolated limb perfusion and topical imiquimod

Published:2006-05-12 Issue:2 Volume:155 Page:488-491
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Utikal J.,Zimpfer A.,Thoelke A.,Figl R.,Hildenbrand R.,Kettelhack C.,Goerdt S.,Schadendorf D.,Ugurel S.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2006.07333.x/fullpdf

Reference11 articles.

1. Management of in-transit metastases from cutaneous malignant melanoma;Hayes;Br J Surg,2004

2. Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor;Kettelhack;Langenbecks Arch Chir Suppl Kongressbd,1996

3. Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma;Kettelhack;Dtsch Med Wochenschr,1997

4. Hyperthermia inhibits angiogenesis;Fajardo;Radiat Res,1988

5. The impact of surgery and mild hyperthermia on tumor response and angioneogenesis of malignant melanoma in a rat perfusion model;Pelz;BMC Cancer,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in non and minimal-invasive transcutaneous delivery of immunotherapy for cancer treatment;Biomedicine & Pharmacotherapy;2020-11

2. The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature;Dermatologic Therapy;2020-09-07

3. Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy;JAAD Case Reports;2018-03

4. Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial;OncoImmunology;2018-01-15

5. Topical Immune Response Modifiers: Adjuvants;Clinical and Basic Immunodermatology;2017